Home›Companies›Healthcare›TranspareRx

TranspareRx Corp

Updated Oct 27, 2026·Latest SEC filing Jun 8, 2023·Suggest an edit

About TranspareRx

TranspareRx is a private company based in Naples, Florida, incorporated in 2020 in Nevada. It has reported $0 raised in two offerings on Form D since December 2020. Its chief executive is David Harrell.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetJun 8, 2023$0of $2.8M target0—EquityRule 506(c)Form D ↗
Not yetDec 3, 2020$0of $4.0M target0—EquityRule 506(c)Form D ↗
Total, two offerings$0

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on TranspareRx's Form D filed Jun 8, 2023.

NB
Neil Bajaj
Executive officer
TG
MS
Michael Sims
Director
MO
ML
Michael Lowe
Executive officer and director
DH
David Harrell
CEO and director
KS
Karthik Sundaram
Executive officer

Sources

  1. SECTranspareRx Corp filing history